- Home
- CUE vs FTLF Comparison
CUE vs FTLF Comparison
Compare CUE & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | FTLF |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.5M | 112.0M |
| IPO Year | 2017 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CUE | FTLF |
|---|---|---|
| Price | $27.00 | $10.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $120.00 | $21.50 |
| AVG Volume (30 Days) | ★ 160.0K | 11.1K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $27,466,000.00 | $21,744,000.00 |
| Revenue This Year | N/A | $45.76 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ N/A | $60.06 |
| Revenue Growth | ★ 195.75 | 11.52 |
| 52 Week Low | $0.17 | $8.67 |
| 52 Week High | $45.50 | $20.98 |
Technical Indicators
Market Signals| Indicator | CUE | FTLF |
|---|---|---|
| Relative Strength Index (RSI) | 44.09 | 45.96 |
| Support Level | $24.49 | $9.47 |
| Resistance Level | $33.73 | $12.55 |
| Average True Range (ATR) | 3.15 | 0.54 |
| MACD | -0.78 | -0.02 |
| Stochastic Oscillator | 16.97 | 39.53 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.